EP 1443904 A2 20040811 - ORALLY ADMINISTERED PHARMACEUTICAL PREPARATION COMPRISING LIPOSOMICALLY ENCAPSULATED PACLITAXEL
Title (en)
ORALLY ADMINISTERED PHARMACEUTICAL PREPARATION COMPRISING LIPOSOMICALLY ENCAPSULATED PACLITAXEL
Title (de)
ORAL VERABREICHBARE PHARMAZEUTISCHE ZUBEREITUNG UMFASSEND LIPOSOMAL VERKAPSELTES TAXOL
Title (fr)
PREPARATION PHARMACEUTIQUE D'ADMINISTRATION ORALE CONTENANT DU PACLITAXEL ENCAPSULE DANS DES LIPOSOMES
Publication
Application
Priority
- DE 0204120 W 20021106
- DE 10154464 A 20011108
Abstract (en)
[origin: WO03039437A2] The invention relates to pharmaceutical preparations, which are suitable for the oral application of liposomically encapsulated paclitaxel, its derivatives and taxane. Said preparations preferably contain at least one immunomodulator, preferably cyclosporine, and/or at least one cytokine, preferably PEG-cytokine.
IPC 1-7
IPC 8 full level
A61K 9/08 (2006.01); A61K 9/127 (2006.01); A61K 9/14 (2006.01); A61K 9/19 (2006.01); A61K 9/20 (2006.01); A61K 9/48 (2006.01); A61K 31/337 (2006.01); A61K 38/13 (2006.01); A61K 38/19 (2006.01); A61K 45/00 (2006.01); A61K 47/12 (2006.01); A61K 47/24 (2006.01); A61K 47/28 (2006.01); A61K 47/30 (2006.01); A61K 47/34 (2006.01); A61P 35/00 (2006.01); C07D 305/14 (2006.01)
CPC (source: EP US)
A61K 9/127 (2013.01 - EP US); A61K 9/1271 (2013.01 - EP US); A61K 31/337 (2013.01 - EP US); A61K 38/13 (2013.01 - EP US); A61K 38/19 (2013.01 - EP US); A61P 35/00 (2017.12 - EP)
Citation (search report)
See references of WO 03039437A2
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LI LU MC NL PT SE SK TR
DOCDB simple family (publication)
WO 03039437 A2 20030515; WO 03039437 A3 20030710; AU 2002350386 A1 20030519; DE 10154464 A1 20030522; DE 10154464 B4 20051020; EP 1443904 A2 20040811; JP 2005511578 A 20050428; US 2005019386 A1 20050127
DOCDB simple family (application)
DE 0204120 W 20021106; AU 2002350386 A 20021106; DE 10154464 A 20011108; EP 02785050 A 20021106; JP 2003541531 A 20021106; US 49503904 A 20040917